Boston Scientific stock price forecast: $45.86 resistance as BSX trades flat

Traders Union
All News
Financial News
Boston Scientific rises 0.83% today

Highlights

Fullerton Fund Management Co Ltd. increased its stake in Boston Scientific by 184.3% in Q4, signaling strong institutional demand.
Despite some portfolio rebalancing by the State of Wisconsin Investment Board, net institutional flows remain overwhelmingly positive for Boston Scientific.
Technical signals point to sustained downside risk, with strong bearish momentum; BSX is expected to trade between $44.02 and $46.64 in the coming days.

Institutional inflows rise as Fullerton increases stake and Wisconsin trims

A substantial increase in institutional ownership has provided a notable demand boost for Boston Scientific, as Fullerton Fund Management Co Ltd. increased its holdings by 184.3% in the fourth quarter, now owning 598,174 shares according to its most recent SEC filing. Large-scale accumulation by a prominent fund highlights heightened investor confidence and can act as a catalyst for upward price movement. Meanwhile, Markets Daily reported that the State of Wisconsin Investment Board decreased its stake by 8.8% over the same period, reflecting some portfolio rebalancing but with the net effect dominated by new large-scale inflows.

Bearish momentum persists as price lags below all major averages

BSX is currently positioned below the MA-20 ($45.92) and MA-50 ($46.80) on the hourly chart, and remains well under the long-term MA-200 at $81.51. Immediate resistance is identified at the Ichimoku Kijun level of $45.86. Momentum analysis shows MACD at Strong Sell, while the ADX reads as Neutral, indicating negative momentum without a dominant trend. RSI is at 39.22, signaling a Sell, CCI also suggests Sell, and Stochastic RSI is Neutral. The BBP points to ongoing seller control, while divergence among oscillators provides only limited counterbalance to prevailing bearish pressure.

Further downside likely as resistance and support levels define range

Over the next two to three trading days, BSX is expected to trade within a typical volatility band between $44.02 and $46.64. The probabilities currently favor further declines, with a 22% chance of upside and a 78% probability of further downside. For a bullish scenario, the price would need to overcome resistance at $45.86. A bearish outcome would be confirmed by a move below near-term support at $44.02, suggesting the stock may settle within or just below this range.

Anton Kharitonov, expert at Traders Union, notes that despite clear signs of institutional accumulation, technicals remain heavily bearish. He sees that the sharp increase in Fullerton Fund Management’s stake signals confidence, but price action and momentum indicators point to more downside. Until $45.86 is decisively reclaimed, caution is warranted. "Without a strong breakout above resistance, the risks of renewed declines remain the core scenario for BSX," he states.

Earlier, analysts noted a persistently bearish technical outlook for Boston Scientific, citing ongoing downside momentum across major indicators. The recent surge in institutional buying injects new potential for a reversal, but with selling pressure still dominant, traders should closely monitor whether the stock can sustain a move above resistance at $45.86 in the days ahead.

Source of Data: BSX Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.